Search results
Results from the WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
(Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...
For premium support please call: 800-290-4726 more ways to reach us
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Get the latest news, politics, sports, and weather updates on AOL.com.
See full forecast. In Other News. Entertainment. Entertainment. USA TODAY. ... Stock market today: Global shares are mixed after New Year holiday. Chinese shares si…